Integrins, angiogenesis and vascular cell survival.
暂无分享,去创建一个
[1] H. Kleinman,et al. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro , 1989, Cell.
[2] M. Bissell,et al. Multi‐faceted regulation of cell differentiation by extracellular matrix , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] M. Schwartz,et al. Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms , 1993, The Journal of cell biology.
[4] H. Kleinman,et al. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures , 1988, The Journal of cell biology.
[5] J. Azizkhan,et al. In vitro model of angiogenesis using a human endothelium‐derived permanent cell line: Contributions of induced gene expression, G‐proteins, and integrins , 1992, Journal of cellular physiology.
[6] H. Hammes,et al. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization , 1996, Nature Medicine.
[7] J. Becker,et al. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. , 1996, The Journal of clinical investigation.
[8] D. Cheresh,et al. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.
[9] Z. Werb,et al. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] W. Risau. Differentiation of endothelium , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[12] J. Brugge,et al. Integrins and signal transduction pathways: the road taken. , 1995, Science.
[13] F. Sarkar,et al. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.
[14] Kenneth M. Yamada,et al. Integrin transmembrane signaling and cytoskeletal control. , 1995, Current opinion in cell biology.
[15] M. Schwartz,et al. The extracellular matrix as a cell survival factor. , 1993, Molecular biology of the cell.
[16] R. Timpl,et al. Comparison of Disintegrins with Limited Variation in the RGD Loop in Their Binding to Purified Integrins αIIbβ3, αVβ3 and α5β1 and in Cell Adhesion Inhibition , 1994 .
[17] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[18] E. Bonanno,et al. Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide. , 1991, The American journal of pathology.
[19] E. White,et al. Life, death, and the pursuit of apoptosis. , 1996, Genes & development.
[20] S. Frisch,et al. Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.
[21] R. Timpl,et al. Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1 , 1991, FEBS letters.
[22] W. Stetler-Stevenson,et al. Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.
[23] R. Schlegel,et al. Apoptosis and the cell cycle , 1995, Journal of cellular biochemistry.
[24] T. Hunter,et al. Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage , 1996, Science.
[25] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[26] K. Sekiguchi,et al. Peptide ligands for integrin alpha v beta 3 selected from random phage display libraries. , 1995, Biochemistry.
[27] K. Hodivala,et al. Cell Adhesion: Fibronectin and integrin knockouts come unstuck , 1994, Current Biology.
[28] B. Coller,et al. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel , 1991 .
[29] F M Watt,et al. Regulation of development and differentiation by the extracellular matrix. , 1993, Development.
[30] F. Re,et al. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells , 1994, The Journal of cell biology.
[31] A. Laurenza,et al. Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation , 1993, Journal of cellular biochemistry.
[32] D. Cheresh,et al. An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization , 1995 .
[33] D. Cheresh,et al. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. , 1995, Journal of cell science.
[34] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[35] J. Gamble,et al. Regulation of in vitro capillary tube formation by anti-integrin antibodies , 1993, The Journal of cell biology.
[36] James M. Roberts,et al. A link between cyclin A expression and adhesion-dependent cell cycle progression. , 1993, Science.